New device and method for treatment of heart failure patients
|Coordinator||SYNTACH AB - Synergio AB|
|Funding from Vinnova||SEK 1 000 000|
|Project duration||June 2017 - December 2017|
|Venture||Swelife and Medtech4Health- Project proposals to improve health|
Purpose and goal
This sub project has brought the project closer to the final product which is a permanent active implant that increases the longitudinal movement of the left ventricle and thereby increases cardiac pumping on heart failure patients. The primary objective was to identify an adequate animal model. The development work with the animal is still ongoing. The prototypes have been further developed. Cooperation between the three project partners has been intensified. Preliminary computer model is available.
Expected results and effects
The primary objective of this sub project was to identify an adequate animal model to be used for the verification of the products function and to create a complete requirement specification for the rest of the project. A unique animal model is under development after new ethical approval. The prototypes have been further developed. A computer model that calculates new parameters for the hearts efficiency and stroke work has been developed. These new parameters will be used to verify the impact of the prototypes.
Planned approach and implementation
Initially in the sub project we tried to find an existing animal model to be used but as this could not be identified we had to apply for an updated ethical approval that included both the development of the animal model itself and the verification test of the products using the new animal model. The development of the new animal model is still going on. The prototypes have also been further developed and have been tested in the already existing acute animal model. The computer model has been implemented in existing software.